CD5 and neoplasm: Although many studies demonstrated that 4-1BB CAR is safe with increased persistence, in case of CD5+ tumor targeting, CD5-4-1BB CAR showed reduced efficacy compared with CD5-CD28z CAR due to enhanced T cell fratricide.